SANDEEP KAUR
⚠️ High Risk
FEI: 3023500640 • Punjab • INDIA
FEI Number
3023500640
Location
Punjab
Country
INDIAAddress
Vtc Gehal Mazari Po Mok, , Punjab, , India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 9/26/2022 | 56GDY99ANTIFUNGAL N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 66YDY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 66YDY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 61FDY54CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 66YDY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 62ODY26DORZOLAMIDE HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II) | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 61JDY08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC) | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 62TDY07PANTOPRAZOLE SODIUM | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 62ODY43METOPROLOL SUCCINATE (ANTI-HYPERTENSIVE - PART II) | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 61PDY31GLIMEPIRIDE (ANTI-DIABETIC) | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is SANDEEP KAUR's FDA import refusal history?
SANDEEP KAUR (FEI: 3023500640) has 10 FDA import refusal record(s) in our database, spanning from 9/26/2022 to 9/26/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SANDEEP KAUR's FEI number is 3023500640.
What types of violations has SANDEEP KAUR received?
SANDEEP KAUR has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about SANDEEP KAUR come from?
All FDA import refusal data for SANDEEP KAUR is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.